Investor Relations

Press Release

June 6, 2022

Amphastar Pharmaceuticals to Present at the Jefferies Healthcare Conference

More
May 24, 2022

Amphastar Receives FDA Approval for Regadenoson

More
May 9, 2022

Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2022

More
May 2, 2022

Amphastar Pharmaceuticals to Release First Quarter Earnings and Hold Conference Call on May 9, 2022

More
April 8, 2022

Amphastar Receives FDA Approval for Ganirelix Acetate Injection

More
April 6, 2022

Amphastar Pharmaceuticals to Present at the 21st Annual Needham Virtual Healthcare Conference

More
March 10, 2022

Amphastar Pharmaceuticals Reports Financial Results for the Three Months and Full-Year Ended December 31, 2021

More
March 3, 2022

Amphastar Pharmaceuticals to Release Fourth Quarter Earnings and Hold Conference Call on March 10th, 2022

More
December 29, 2021

Amphastar Receives FDA Tentative Approval for Vasopressin

More
November 22, 2021

Amphastar Pharmaceuticals to Present at the Piper Sandler 33rd Annual Virtual Healthcare Conference

More
Youtube